Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 47 of the 49 references it cites were found in a registry or an index; 29 of the 84 sources its claims cite were checked for support.

Nightmare Disorder and Isolated Sleep Paralysis

Open access
Stefani, Ambra, Högl, Birgit · 2021 · Neurotherapeutics

Abstract

Nightmare disorder and recurrent isolated sleep paralysis are rapid eye movement (REM) parasomnias that cause significant distress to those who suffer from them. Nightmare disorder can cause insomnia due to fear of falling asleep through dread of nightmare occurrence. Hyperarousal and impaired fear extinction are involved in nightmare generation, as well as brain areas involved in emotion regulation. Nightmare disorder is particularly frequent in psychiatric disorders and posttraumatic stress disorder. Nonmedication treatment, in particular imagery rehearsal therapy, is especially effective. Isolated sleep paralysis is experienced at least once by up to 40% of the general population, whereas recurrence is less frequent. Isolated sleep paralysis can be accompanied by very intense and vivid hallucinations. Sleep paralysis represents a dissociated state, with persistence of REM atonia into wakefulness. Variations in circadian rhythm genes might be involved in their pathogenesis. Predisposing factors include sleep deprivation, irregular sleep-wake schedules, and jetlag. The most effective therapy consists of avoiding those factors.

Overview

CoChat Summary

TL;DR

Nightmare disorder and recurrent isolated sleep paralysis are REM parasomnias that cause clinically significant distress, with nightmare disorder linked to hyperarousal and impaired fear extinction and RISP representing a dissociated state of REM atonia persisting into wakefulness. Nonmedication treatment, especially imagery rehearsal therapy, is effective for nightmare disorder, while avoiding sleep deprivation, irregular sleep–wake schedules, and jetlag is central for RISP.

Key findings

  • Nightmare disorder is common in psychiatric populations: a systematic review of 22 studies found an average prevalence of 38.9% in adults with a psychiatric disorder, including 66.7% in PTSD, 37.3% in mood disorders, 31.1% in personality disorders, and 15.6% in anxiety disorders. Sporadic nightmares were reported in 22% of Austrian adults and 36.2% of men and 45.1% of women in Finland; frequent nightmares were reported in 2.9% of men and 4.4% of women in Finnish surveys.
  • Among individuals with above-average psychopathology scores, 24.9% had clinically significant nightmare symptoms, but 62.2% had not discussed these symptoms with a healthcare provider. In inflammatory arthritis, 35% met criteria for REM sleep parasomnias, with active nightmare disorder in 21%.
  • Isolated sleep paralysis is experienced at least once by up to 40% of the general population, with most studies suggesting 15–40% of younger individuals and some reporting ~5% or 6%; recurrence is less frequent. It can include intense visual, tactile, or auditory hallucinations or a sensed presence, and predisposing factors include sleep deprivation, irregular sleep–wake schedules, jetlag, and supine position.
  • For PTSD-associated nightmares, prazosin 1–3 mg at bedtime is considered first-line pharmacologically despite large multicenter trials failing to show benefit versus placebo; AASM downgraded its recommendation but still considers it first-line, supported by a meta-analysis showing statistically significant benefit on PTSD symptoms and sleep disturbances. Imagery rehearsal therapy is recommended for PTSD-associated nightmares and nightmare disorder.

Methods

  • Narrative review synthesizing ICSD-3 and DSM-5 diagnostic criteria, prevalence data, polysomnographic and fMRI findings, etiology/pathophysiology, and treatment recommendations for nightmare disorder and recurrent isolated sleep paralysis.
  • Evidence is drawn from cited literature, including population surveys, a systematic review of 22 studies, polysomnographic studies, clinical trials, and meta-analyses; no primary data collection is reported.
  • The paper does not describe a systematic search strategy, inclusion criteria, or formal quality appraisal.

Limitations

  • The paper states that determining the true prevalence of nightmare disorder is difficult because most epidemiological studies fail to distinguish it from nightmares, and nightmares are often underreported and undetected.
  • The paper notes conflicting data on the impact of low socioeconomic status on nightmare incidence and on the role of sleep apnea in nightmare generation; it also states that genetic studies for RISP are lacking and genome-wide association studies have not been performed.
  • Evident from the text: this is a narrative review without a reported systematic search or quality appraisal, and treatment conclusions rely partly on guidelines and mixed trial results, such as the contradictory findings for prazosin.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1007/s13311-020-00966-8

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

26 Valid · 0 Not valid · 47 Not checked · 9 Own results and interpretations

24 more claims · 6 with their cited sources checked

Create a free account to see all 82 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 24
  • It may state two separate claims as one. 37

Create a free account to see these claims.

Citations

Cites

Show all 49 references

Cited by

See all 66

Metadata

Authors
Stefani, A., & Högl, B.
Affiliations
Innsbruck Medical University (AT)
Corresponding author
Högl, Birgit
Venue
Neurotherapeutics
Publisher
Elsevier BV
Published
2021-01
Volume
18
Issue
1
Pages
100-106
ISSN
1878-7479 (ISSN-L)
OpenAlex
W3110090675
Cited by
66
References
49
Citations by year
2026: 5 · 2025: 6 · 2024: 21 · 2023: 16 · 2022: 12 · 2021: 6
FWCI
1.24
Type
journal article
Language
en
Open access
Licence
Locations
  • Neurotherapeutics (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Medizinische Universität Innsbruck
  • Universität Innsbruck
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
  • Health Sciences › Medicine › Clinical Neurology › Restless Legs Syndrome Research
Keywords
nightmare disorder, insomnia, fear extinction, hyperarousal, emotion regulation, post-traumatic stress disorder, imagery rehearsal therapy, REM atonia, circadian rhythm genes, sleep deprivation, jet lag, dissociation, hallucinations
MeSH terms
Dreams, Humans, Sleep, REM, Sleep Paralysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Nightmare Disorder and Isolated Sleep Paralysis. https://app.cochat.ai/papers/10.1007/s13311-020-00966-8
The paper
Stefani, A., & Högl, B. (2021). Nightmare Disorder and Isolated Sleep Paralysis. Neurotherapeutics. https://doi.org/10.1007/s13311-020-00966-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.